Wilm's Tumor 1 Protein Vaccine to Treat Cancers of the Blood

NCT00923910 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

10

Enrollment

NIH

Sponsor class

Conditions

Leukemia, Acute Myelogenous (AML)
Leukemia, Acute Lymphocytic (ALL)
Leukemia, Chronic Myelogenous (CML)
Myelodysplastic Syndrome (MDS)
Non-Hodgkin's Lymphoma (NHL)

Interventions

DRUG: WT1 Peptide-Pulsed Dendritic Cells
DRUG: Donor Lymphocytes
DRUG: IL-4
DRUG: KLH
DRUG: WT1 Peptides
DRUG: Endotoxin
DRUG: Diphenhydramine
DRUG: Acetaminophen

Sponsor

National Cancer Institute (NCI)